Fifty clinical isolates of
Pseudomonas aeruginosa were tested for inhibition of growth of clinical isolates of Escherichiacoli,
Salmonella infantis, Klebsiella pneumoniae and other Gram-negative bacteria in the authors' laboratory.
Pseudomonas aeruginosa was strongly active against both
E. coli and
Enterobacter cloacae, with 89.4% and 94.7% inhibition respectively, but weakly active against
S. infantis, K. pneumoniae and
Proteus mirabilis with 56.3%, 48.8% and 23.8% inhibition, respectively. The pigmented strains were found to have stronger antimicrobial activity than the unpigmented strains.
Pyocyanin, the major metabolite of
Pseudomonas aeruginosa, has been shown to inhibit
Escherichia coli,
Proteus spp. and other Gram-negative bacteria, by research with a few strains of
P. aeruginosa and a single inhibited strains. However, little attempt has been made to determine the inhibitory action of many strains of
P. aeruginosa against a large number of clinical isolates such as
Escherichia spp.,
Klebsiella spp., and
Salmonella spp., up to now. For this reason, in this study we examined 50 randomly selected clinical isolates of
P. aeruginosa for inhibition of growth of a wide range of Gram-negative bacteria, including 30 strains of
E. coli, 30 of
K. pneumoniae, 30 of
S. infantis, 6 of
Enterobacter cloacae and 9 of
Proteus mirabilis.
抄録全体を表示